{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:34:15Z","timestamp":1769560455940,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.numecd.2005.04.005","type":"journal-article","created":{"date-parts":[[2005,10,21]],"date-time":"2005-10-21T11:13:45Z","timestamp":1129893225000},"page":"137-147","source":"Crossref","is-referenced-by-count":39,"title":["Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism"],"prefix":"10.1016","volume":"16","author":[{"given":"A.C.","family":"Pessina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ciccariello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Stoico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Gussoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Scotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Muggeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2005.04.005_bib1","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","article-title":"Blood pressure, stroke, and coronary heart disease \u2013 part 2, short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context","volume":"335","author":"Collins","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2005.04.005_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00004872-199605000-00001","article-title":"The benefits of lowering elevated blood pressure: a critical review of studies of cardiovascular morbidity and mortality in hypertension","volume":"14","author":"Hansson","year":"1996","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2005.04.005_bib3","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/S0140-6736(98)04311-6","article-title":"Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial","volume":"351","author":"Hansson","year":"1998","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.numecd.2005.04.005_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198600311-00004","article-title":"Hypertension: relationship with other risk factors","volume":"31","author":"Kannel","year":"1986","journal-title":"Drugs"},{"key":"10.1016\/j.numecd.2005.04.005_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.7326\/0003-4819-90-1-85","article-title":"Cholesterol in the prediction of atherosclerotic disease. New perspectives based on Framingham Study","volume":"90","author":"Kannel","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2005.04.005_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00004872-198504000-00010","article-title":"Predictors of cardiovascular morbidity in treated hypertension: results from the primary prevention trial in Goteborg","volume":"3","author":"Samuelsson","year":"1985","journal-title":"Sweden. J Hypertens"},{"key":"10.1016\/j.numecd.2005.04.005_bib7","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/0002-8703(91)90729-2","article-title":"Is hyperglycaemia associated with cardiovascular disease? The Framingham Study","volume":"2","author":"Wilson","year":"1991","journal-title":"Am Heart J"},{"issue":"Suppl. 2","key":"10.1016\/j.numecd.2005.04.005_bib8","first-page":"68","article-title":"Consensus Statement. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes","volume":"15","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2005.04.005_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"Gaede","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.numecd.2005.04.005_bib10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.CIR.83.1.356","article-title":"Un updated coronary risk profile. A statement for health professionals","volume":"83","author":"Anderson","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2005.04.005_bib11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.numecd.2005.04.005_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00003495-199549020-00011","article-title":"Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia","volume":"49","author":"Fulton","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.numecd.2005.04.005_bib13","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.270.6.713","article-title":"For the Treatment of Mild Hypertension Study Research Group. Treatment of Mild Hypertension Study: final results","volume":"270","author":"Neaton","year":"1993","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.numecd.2005.04.005_bib14","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.275.20.1549","article-title":"Long term effects on plasma lipids of diet and drugs to treat hypertension","volume":"275","author":"Grimm","year":"1996","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.numecd.2005.04.005_bib15","article-title":"Principal results of the hypertension and lipid trial (HALT): a multicenter study of doxazosin in patients with hypertension","volume":"131","author":"Levy","year":"1996","journal-title":"Am Hearth J"},{"key":"10.1016\/j.numecd.2005.04.005_bib16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1742-1241.2001.tb11165.x","article-title":"Meta analysis of studies using selective alfa1-blockers in patients with hypertension and type 2 diabetes","volume":"55","author":"Glanz","year":"2001","journal-title":"Int J Clin Pract"},{"issue":"1","key":"10.1016\/j.numecd.2005.04.005_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/080370598437556","article-title":"A 5-year comparison of doxazosin and atenolol in patients with mild-to-moderate hypertension: effects on blood pressure, serum lipids, and coronary heart disease risk","volume":"7","author":"Daae","year":"1998","journal-title":"Blood Press"},{"key":"10.1016\/j.numecd.2005.04.005_bib18","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/0002-8703(88)90229-3","article-title":"A single-blind study of doxazosin in the treatment of mild-to moderate essential hypertensive patients with concomitant non-insulin-dependent diabetes mellitus","volume":"116","author":"Castrignano","year":"1988","journal-title":"Am Heart J"},{"key":"10.1016\/j.numecd.2005.04.005_bib19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s005920050111","article-title":"Effect of doxazosin in mild to moderate hypertensive patients with insulin-dependent diabetes mellitus","volume":"35","author":"Cal\u00f2","year":"1998","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.numecd.2005.04.005_bib20","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1001\/jama.283.15.1967","article-title":"Major cardiovascular events in hypertensive patients randomised to doxazosin vs chlortalidone","volume":"283","author":"The ALLHAT officers and coordinators for the ALLHAT Collaborative Research Group","year":"2000","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.numecd.2005.04.005_bib21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1161\/01.HYP.0000086521.95630.5A","article-title":"Diuretic versus alfa-blocker as first-step antihypertensive therapy. Final results from the antihypertensive and lipid-lowering treatment to prevent hearth attack trial (ALLHAT)","volume":"42","author":"The ALLHAT officers and coordinators for the ALLHAT Collaborative Research Group","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2005.04.005_bib22","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00004872-200306000-00001","article-title":"2003 European Society of Hypertension-European Society of Cardiology Guidelines for the management of arterial hypertension","volume":"21","author":"Guidelines Committee","year":"2003","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2005.04.005_bib23","doi-asserted-by":"crossref","unstructured":"1999 World Health Organization \u2013 International Society of Hypertension Guidelines for the management of hypertension. J Hypertens 1999;17:151\u201383.","DOI":"10.1097\/00004872-199917020-00001"},{"key":"10.1016\/j.numecd.2005.04.005_bib24","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1001\/archinte.157.21.2413","article-title":"The Sixth Report of the Joint National Committee on Prevention, detection, Evaluation and Treatment of High blood Pressure","volume":"157","year":"1997","journal-title":"Arch Int Med"},{"key":"10.1016\/j.numecd.2005.04.005_bib25","unstructured":"Ceriello A, Squatrito S, editors. Raccomandazioni per la valutazione e la riduzione del rischio cardiovascolare nel diabete \u201c1999\u201d. Il Diabete 1999;11(Suppl. to n.3):1\u201314."},{"key":"10.1016\/j.numecd.2005.04.005_bib26","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2005.04.005_bib27","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1742-1241.2000.tb11839.x","article-title":"The role of alpha 1-blockers in combination therapy for hypertension","volume":"54","author":"Zusman","year":"2000","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.numecd.2005.04.005_bib28","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/00004872-200208000-00001","article-title":"Systolic and diastolic blood pressure control in antihypertensive drug trials","volume":"20","author":"Mancia","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2005.04.005_bib29","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1742-1241.2001.tb11165.x","article-title":"Meta-analysis of studies using selective alpha 1-blockers in patients with hypertension and type 2 diabetes","volume":"55","author":"Glanz","year":"2001","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.numecd.2005.04.005_bib30","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0895-7061(99)00225-3","article-title":"The addition of doxazosin to the therapeutic regimen of hypertensive patients inadequately controlled with other antihypertensive medications: a randomised, placebo-controlled study","volume":"13","author":"Black","year":"2000","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.numecd.2005.04.005_bib31","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1172\/JCI114644","article-title":"Decreased effect of insulin to stimulate skeletal muscle blood-flow in obese man: a novel mechanism for insulin resistance","volume":"85","author":"Laakso","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.numecd.2005.04.005_bib32","first-page":"219","article-title":"Effects of selective alpha1 and beta 1 adrenoceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity","volume":"8","author":"Andersson","year":"1994","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.numecd.2005.04.005_bib33","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0895-7061(95)00396-7","article-title":"Metabolic effects of doxazosin and enalapril in hypertriglyceridemic, hypertensive men","volume":"9","author":"Andersson","year":"1996","journal-title":"Am J Hypertens"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475305001134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475305001134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T05:47:33Z","timestamp":1706680053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475305001134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0939475305001134"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2005.04.005","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}